D-2-hydroxyglutarate (2HG) characterizes IDH-mutant gliomas and can be detected and quantified with edited MRS (MEGA-PRESS). Here, we investigated the clinical, radiological, and molecular parameters affecting 2HG levels.

In vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of IDH-Mutant Diffuse Gliomas: The IDASPE Prospective Study / Di Stefano, Anna Luisa; Nichelli, Lucia; Berzero, Giulia; Valabregue, Romain; Touat, Mehdi; Capelle, Laurent; Pontoizeau, Clément; Bielle, Franck; Lerond, Julie; Giry, Marine; Villa, Chiara; Baussart, Bertrand; Dehais, Caroline; Galanaud, Damien; Baldini, Capucine; Savatovsky, Julien; Dhermain, Frédéric; Deelchand, Dinesh K; Ottolenghi, Chris; Lehericy, Stephane; Marjańska, Małgorzata; Branzoli, Francesca; Sanson, Marc. - In: NEUROLOGY. - ISSN 0028-3878. - (2022). [Epub ahead of print] [10.1212/WNL.0000000000201137]

In vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of IDH-Mutant Diffuse Gliomas: The IDASPE Prospective Study

Berzero, Giulia;
2022-01-01

Abstract

D-2-hydroxyglutarate (2HG) characterizes IDH-mutant gliomas and can be detected and quantified with edited MRS (MEGA-PRESS). Here, we investigated the clinical, radiological, and molecular parameters affecting 2HG levels.
2022
2-hydroxyglutarate (2HG)
IDH1/2 mutations
diffuse gliomas
edited MR spectroscopy
noninvasive detection
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/133911
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 7
social impact